$2.95 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 28 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 47.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPR | Sell | SPIRIT AEROSYSTEMS HLDGS INC | $334,912,000 | -31.9% | 4,645,750 | -13.3% | 11.36% | +20.1% |
VST | Buy | VISTRA ENERGY CORP | $306,120,000 | +1.9% | 13,373,518 | +10.8% | 10.39% | +79.7% |
ITRI | Sell | ITRON INC | $240,542,000 | -30.6% | 5,086,532 | -5.8% | 8.16% | +22.3% |
JCI | Buy | JOHNSON CTLS INTL PLC | $238,220,000 | -9.0% | 8,034,412 | +7.4% | 8.08% | +60.4% |
HZNP | Sell | HORIZON PHARMA PLC | $209,579,000 | -27.5% | 10,725,642 | -27.3% | 7.11% | +27.8% |
JD | Buy | JD COM INCspon adr cl a | $160,141,000 | -14.1% | 7,651,273 | +7.1% | 5.43% | +51.5% |
ETRN | New | EQUITRANS MIDSTREAM CORPORAT | $141,880,000 | – | 7,086,893 | +100.0% | 4.81% | – |
RTRX | Sell | RETROPHIN INC | $133,763,000 | -28.6% | 5,910,853 | -9.3% | 4.54% | +25.9% |
GWPH | Sell | GW PHARMACEUTICALS PLCads | $131,009,000 | -49.0% | 1,345,198 | -9.6% | 4.44% | -10.1% |
NXPI | New | NXP SEMICONDUCTORS N V | $129,029,000 | – | 1,760,765 | +100.0% | 4.38% | – |
QRVO | New | QORVO INC | $128,319,000 | – | 2,112,943 | +100.0% | 4.35% | – |
ISBC | Sell | INVESTORS BANCORP INC NEW | $112,672,000 | -35.3% | 10,833,824 | -23.7% | 3.82% | +14.1% |
W | Buy | WAYFAIR INCcl a | $109,849,000 | -16.7% | 1,219,464 | +36.6% | 3.73% | +46.9% |
ZGNX | Sell | ZOGENIX INC | $108,864,000 | -58.6% | 2,985,834 | -43.7% | 3.69% | -27.1% |
ACOR | Sell | ACORDA THERAPEUTICS INC | $85,550,000 | -38.7% | 5,491,035 | -22.7% | 2.90% | +8.0% |
SRC | New | SPIRIT RLTY CAP INC NEW | $68,965,000 | – | 1,956,456 | +100.0% | 2.34% | – |
CNMD | Sell | CONMED CORP | $62,220,000 | -34.8% | 969,160 | -19.6% | 2.11% | +14.9% |
PTCT | Buy | PTC THERAPEUTICS INC | $55,837,000 | -26.5% | 1,626,965 | +0.6% | 1.89% | +29.5% |
PRTA | Buy | PROTHENA CORP PLC | $47,567,000 | -7.1% | 4,618,164 | +17.9% | 1.61% | +63.7% |
ETM | Sell | ENTERCOM COMMUNICATIONS CORPcl a | $33,624,000 | -46.5% | 5,888,683 | -25.9% | 1.14% | -5.6% |
YMAB | Y MABS THERAPEUTICS INC | $31,312,000 | -25.7% | 1,587,566 | 0.0% | 1.06% | +30.8% | |
LJPC | Sell | LA JOLLA PHARMACEUTICAL CO | $22,513,000 | -56.8% | 2,387,336 | -7.8% | 0.76% | -23.9% |
AYI | ACUITY BRANDS INC | $21,373,000 | -26.9% | 185,930 | 0.0% | 0.72% | +28.8% | |
THC | Sell | TENET HEALTHCARE CORP | $14,924,000 | -71.8% | 870,695 | -53.1% | 0.51% | -50.2% |
ICPT | INTERCEPT PHARMACEUTICALS IN | $6,547,000 | -20.2% | 64,961 | 0.0% | 0.22% | +40.5% | |
FOSL | FOSSIL GROUP INC | $6,228,000 | -32.4% | 395,925 | 0.0% | 0.21% | +19.2% | |
SMTA | Sell | SPIRIT MTA REIT | $4,192,000 | -84.9% | 587,940 | -75.6% | 0.14% | -73.4% |
MNKD | MANNKIND CORP | $1,766,000 | -42.1% | 1,666,498 | 0.0% | 0.06% | +1.7% | |
AMSC | Exit | AMERICAN SUPERCONDUCTOR CORP | $0 | – | -19,610 | -100.0% | -0.00% | – |
IFRX | Exit | INFLARX NV | $0 | – | -205,080 | -100.0% | -0.14% | – |
SAFM | Exit | SANDERSON FARMS INC | $0 | – | -76,887 | -100.0% | -0.15% | – |
CVON | Exit | CONVERGEONE HLDGS INC | $0 | – | -1,551,828 | -100.0% | -0.28% | – |
PAGP | Exit | PLAINS GP HLDGS L Pltd partnr int a | $0 | – | -1,055,000 | -100.0% | -0.50% | – |
Exit | RETROPHIN INCnote 2.500% 9/1 | $0 | – | -48,000,000 | -100.0% | -0.95% | – | |
WFTIQ | Exit | WEATHERFORD INTL PLC | $0 | – | -31,019,881 | -100.0% | -1.62% | – |
IWM | Exit | ISHARES TRput | $0 | – | -506,200 | -100.0% | -1.64% | – |
EQT | Exit | EQT CORP | $0 | – | -2,373,631 | -100.0% | -2.02% | – |
MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -4,724,581 | -100.0% | -2.66% | – |
SRC | Exit | SPIRIT RLTY CAP INC NEW | $0 | – | -18,693,585 | -100.0% | -2.90% | – |
SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -726,100 | -100.0% | -4.06% | – |
ARRS | Exit | ARRIS INTL INC | $0 | – | -9,000,000 | -100.0% | -4.50% | – |
FCEA | Exit | FOREST CITY RLTY TR INC | $0 | – | -21,672,157 | -100.0% | -10.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
ISHARES TR | 28 | Q3 2023 | 10.9% |
MANNKIND CORP | 24 | Q3 2023 | 0.5% |
BAIDU INC | 21 | Q2 2018 | 8.6% |
ITRON INC | 21 | Q3 2020 | 12.1% |
RETROPHIN INC | 20 | Q3 2020 | 4.5% |
HARMONIC INC | 19 | Q3 2023 | 10.5% |
JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D | 2024-04-26 |
13F-HR | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13D/A | 2024-01-22 |
13F-HR/A | 2023-11-14 |
13F-HR | 2023-11-14 |
SC 13D | 2023-09-21 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13D/A | 2023-04-12 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.